Venture Houston 2018
Skip Content

2 July 2018

HaploX hacks series B

The SoftBank-backed genetic liquid biopsy technology developer has raised a nine-figure renminbi amount in a Shenzhen Capital-led round.

Author: Robert Lavine, News Editor

HaploX, a China-based genetic sequencing technology provider backed by telecoms group SoftBank, has raised a nine-figure renminbi sum (RMB100m = $15m) in a series B round featuring, China Money Network reported yesterday.